Synthesis and Oral Efficacy of a 4-(Butylethylamino)pyrrolo[2,3-<i>d</i>]pyrimidine:  A Centrally Active Corticotropin-Releasing Factor<sub>1</sub> Receptor Antagonist

Yuhpyng L. Chen, Robert S. Mansbach, Steven M. Winter, Elizabeth Brooks, Judith M. Collins, Michael L. Corman, A. DUNAISKIS, W. Stephen Faraci, Randall J. Gallaschun, Anne W. Schmidt,

Journal of Medicinal Chemistry · 1997 · 113 citations · 13 references

DOIFull text

Open access

Concepts

Abstract

The syntheses of a centrally active nonpeptide CRF1 receptor antagonist 2, butylethyl[2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo [2,3-d]pyrimidin-4-yl]amine (CP-154,526), and its analogs 11-14 and [3H]-2 are reported. The in vitro CRF1 receptor binding affinity in the series 2, the pharmacokinetic properties of 2 in rats, and the anxiolytic-like effects of orally administered 2 are presented.

References

13